Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$21.95 - $26.42 $10,316 - $12,417
470 Added 4.54%
10,830 $275,000
Q4 2023

Feb 12, 2024

SELL
$18.47 - $23.3 $17,214 - $21,715
-932 Reduced 8.25%
10,360 $234,000
Q3 2023

Nov 13, 2023

BUY
$16.98 - $26.1 $191,738 - $294,721
11,292 New
11,292 $210,000
Q1 2021

May 14, 2021

SELL
$32.49 - $45.96 $220,834 - $312,390
-6,797 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$32.59 - $45.26 $32,296 - $44,852
991 Added 17.07%
6,797 $307,000
Q3 2020

Nov 12, 2020

SELL
$32.56 - $38.57 $2,181 - $2,584
-67 Reduced 1.14%
5,806 $202,000
Q2 2020

Aug 14, 2020

BUY
$27.83 - $37.73 $163,445 - $221,588
5,873 New
5,873 $222,000

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $358M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.